Hui Li, PhD

School of Medicine, University of Virginia (USA)

Alexander Hüttenhofer, PhD

Innsbruck Medical University – Biocenter, Innsbruck (Austria)

Intronic tRNAs of mitochondrial origin act as regulators of constitutive and alternative splicing.

David Bates, PhD

Division of Cancer and Stem Cells,School of Medicine,University of Nottingham (UK)

Lucy Donaldson,PhD

University of Nottingham, School of Life Sciences, Nottingham (UK)

Diana Baralle, PhD

University of Southampton, Southampton (UK)

RNA and splicing in Genomic Medicine.

Anthony Schweitzer, PhD

Thermo Fisher Scientific, Santa Clara (USA)

Michele Mishto, PhD

Centre for Inflammation Biology and Cancer Immunology (CIBCI) & Peter Gorer Department of Immunobiology, King’s College London, London (UK)

Immunological relevance and therapeutical applications of post-translational peptide splicing

Matthias Soller, PhD

School of Biosciences, College of Life and Environmental Sciences, University of Birmingham (UK)

Alternative splicing regulation by m6A RNA methylation in Drosophila.

Beatrice Eymin, PhD

Institute For Advanced Biosciences, INSERM U1209/CNRS UMR5309/University Grenoble Alpes, Grenoble (France)

Splice variants of the RTK family: their role in tumor progression and response to therapies.

Ihab Younis, PhD

Carnegie Mellon University Qatar (Qatar)

Targeting Deregulated Splicing in Breast Cancer.

Michele Mishto, PhD

Affiliation, London(UK)

Immunological relevance and therapeutical applications of post-translational peptide splicing